| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 04/04/2006 | USRE39056 4-Azasteroids for treatment of hyperandrogenic conditions |
| 04/04/2006 | US7022870 Antidepressants; sexual disorders; anticancer agnets; hormone replacement therapy |
| 04/04/2006 | US7022849 Quinazoline and pyrido[2,3-d]pyrimidine inhibitors of phosphodiesterase (PDE) 7 |
| 04/04/2006 | US7022733 Estrogen receptor modulators for treating or inhibiting endometriosis |
| 04/04/2006 | US7022730 Protein tyrosine phosphatases inhibitors |
| 04/04/2006 | US7022699 Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators |
| 03/30/2006 | WO2006034090A1 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators |
| 03/30/2006 | WO2006032885A2 2-substituted estrogen sulphamates for inhibition of steroid sulphatase |
| 03/30/2006 | WO2006010560A8 Physiologically active composition |
| 03/30/2006 | WO2003014294A3 Tacis and br3 polypeptides and uses thereof |
| 03/30/2006 | US20060069131 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 03/30/2006 | US20060069103 17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 03/30/2006 | US20060069098 Bone disorders; reduce concentration of parathyroid hormone in blood |
| 03/30/2006 | US20060068045 Method for the preparation of phytoprogestogenic extracts from rhizoma ligusticum chuanxiong and uses thereof |
| 03/30/2006 | DE19911771B4 LHRH-Antagonist, Verfahren zu seiner Herstellung und seiner Verwendung LHRH antagonist, process for its preparation and its use |
| 03/30/2006 | CA2580777A1 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators |
| 03/30/2006 | CA2576614A1 2-substituted estrogen sulphamates for inhibition of steroid sulphatase |
| 03/29/2006 | EP1640019A1 Sustained-release fine granular preparation of human growth hormone and process for producing the same |
| 03/29/2006 | EP1638968A1 Hexahydropyridoisoqinolines as dpp-iv inhibitors |
| 03/29/2006 | EP1638963A1 N-acyl nitrogen heterocycles as ligands of peroxisome proliferator-activated receptors |
| 03/29/2006 | EP1638947A2 Triazole derivatives as inhibitors of 11-beta hydroxysteroid dehydrogenase-1 |
| 03/29/2006 | EP1638927A1 Therapeutic agents |
| 03/29/2006 | EP1638592A1 Synthetic peptide combinations and methods for the production thereof |
| 03/29/2006 | EP1395563B1 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods |
| 03/29/2006 | EP1379253B1 Methods of making and pharmaceutical formulations comprising 7alpha,11beta-dimethyl-17beta-hydroxyestra-4, 14-dien-3-one and 17 esters thereof |
| 03/29/2006 | EP1303270B1 Method for treating cryptorchidism |
| 03/29/2006 | EP1283700B1 Sustained release pharmaceutical compositions for parenteral administration of hydrophilic compounds |
| 03/29/2006 | EP1227086B1 1-substituted phenyl-1-(1h-imidazol-4-yl) alcohols, process for producing the same and use thereof |
| 03/29/2006 | EP1005490B1 Zinc free insulin crystals for use in pulmonary compositions |
| 03/29/2006 | EP0948541B1 Analogs of PTHrP |
| 03/29/2006 | CN1753693A Uses of anti-insulin-like growth factor I receptor antibodies |
| 03/29/2006 | CN1753676A Crystalline non-solvated 1-(4-(2-piperidinylethoxy)phenoxy)-2-(4-methanesulfonylphenyl)-6-hydroxynaphthalene hydrochloride |
| 03/29/2006 | CN1247594C Bicyclic heteroaromatic compounds |
| 03/29/2006 | CN1247576C Novel 7-azaindoles use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
| 03/29/2006 | CN1247567C 2-amino-3-(alkyl)-pyrimidone derivatives as GSKS beta. inhibitors |
| 03/29/2006 | CN1247260C Analogs of parathyroid hormone |
| 03/28/2006 | US7019147 E.,g.,1-[2-(5-Methoxy-benzoimidazol-1-yl)-quinolin-8-yl]-piperidin-4-ylamine; anticarcinogenic and -tumor agent; KDR tyrosine kinase inhibitors; (KDR=kinase inserrt domain recepter) |
| 03/28/2006 | US7019026 Modulators of Protein Tyrosine Phosphatases (PTPases) |
| 03/28/2006 | US7019004 Agonists of imidazolidine-2,4-dione derivatives, chemical intermediates, for treating anxiety, depression, schizophrenia, neurodegenerative diseases, dementia, epilepsy, endocrinological disorders associated with excess of hormone, tumor |
| 03/28/2006 | US7018995 Carbonate and carbamate modified forms of glucocorticoids |
| 03/28/2006 | US7018994 Antiestrogen compound |
| 03/28/2006 | US7018991 A hormonal or antihormonal steroid compound of structure I, amines or amine oxides |
| 03/28/2006 | CA2343459C Pyrazole derivatives as anti-inflammatory/analgesic agents |
| 03/23/2006 | WO2006031786A2 Protein a compositions and methods of use |
| 03/23/2006 | WO2006030324A2 Testosterone stimulant |
| 03/23/2006 | WO2006030306A2 Pindolol for treating premenstrual syndrome and premenstrual dysphoric disorder |
| 03/23/2006 | US20060064767 Nonhuman animal reproducing pathogenic conditions of spinal and bulbar muscular atrophy and remedy for spinal and bulbar muscular atrophy |
| 03/23/2006 | US20060063778 2(R)-Benzyloxymethyl-4-[4-(4-chloro-phenyl)-piperazin-1-yl]-N-hydroxy-3(S)-(4-methoxy-phenyl)-4-oxo-butyramide; inhibiting matrix metalloproteinase; immunosuppression; neuropathic pain |
| 03/23/2006 | US20060063759 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
| 03/23/2006 | US20060063702 Neuromedin U 2 receptor agonists and uses thereof |
| 03/23/2006 | US20060063699 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 03/23/2006 | US20060062772 Polypeptide delivery system |
| 03/23/2006 | CA2580517A1 Protein a compositions and methods of use |
| 03/23/2006 | CA2579514A1 Novel imidazolidin-2-one derivatives as selective androgen receptor modulators (sarms) |
| 03/22/2006 | EP1637531A1 Methanesulfonic acid salt of pyrazolopyrimidine compound, crystal thereof, and process for producing the same |
| 03/22/2006 | EP1637521A1 Novel tricyclic heterocycle compound |
| 03/22/2006 | EP1637138A2 Use of thiazolidinediones to prevent or delay onset of NIDDM |
| 03/22/2006 | EP1635848A1 Methods of managing the symptoms of premenstrual syndrome |
| 03/22/2006 | EP1412357B1 Beta-amino tetrahydroimidazo(1,2-a)pyrazines and tetrahydrotriazolo(4,3-a)pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 03/22/2006 | EP1309324B1 Anticonvulsant derivatives useful for treating and preventing the development of type ii diabetes mellitus and syndrome x |
| 03/22/2006 | EP1301516B1 Modulators of protein tyrosine phosphatases (ptpases) |
| 03/22/2006 | CN1750870A Fine particles, method and device for preparation thereof, and agent for parenteral injection and method for production thereof |
| 03/22/2006 | CN1748675A Composition of rheinic acid compounds and preparing method and use for treating diabetes |
| 03/22/2006 | CN1246328C 17 alfa, 21-dihydroxypregnene esters as antiandrogenic agents |
| 03/22/2006 | CN1246324C Thieno [2,3-d] pyrimidines with combined LH and FSH agonistic activity |
| 03/21/2006 | US7015229 An antagonist of a corticotropin releasing factor (CRF) receptor, treating central nervous system disorders or anxiety disorders, depression and stress |
| 03/21/2006 | US7015226 Hormone inhibitors such as 3-[2(R)-aminopropylamino-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-methylsulfonylbenzyl]-6-methyl-pyrimidine-2,4(1H,3H)-dione, used as anticarcinogenic agents and for prophylaxis of glandular or urogenital disorders |
| 03/21/2006 | US7015213 Use of diazepines for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors |
| 03/21/2006 | US7015200 Carbohydrates conjugated to optionally protected 4-hydroxybutyric acid; enhance the uptake of the drug and allows effective drug delivery to treat GHB-treatable disorders such as sleep disorders or drug withdrawal |
| 03/21/2006 | US7014852 Alkaline phosphatase to induce weight loss or to reduce weight gain |
| 03/21/2006 | CA2124932C Sex steroid activity inhibitors |
| 03/21/2006 | CA2072416C Cyclopropenone derivatives |
| 03/16/2006 | WO2006029371A2 Neuromedin u 2 receptor agonists and uses thereof |
| 03/16/2006 | WO2006028239A1 Carbamoyl-substituted spiro derivative |
| 03/16/2006 | WO2006028226A1 Novel imidazolidine derivative and use thereof |
| 03/16/2006 | WO2006028120A1 Preventive/remedy for obesity |
| 03/16/2006 | WO2006027347A1 15β-SUBSTITUTED STEROIDS HAVING SELECTIVE ESTROGENIC ACTIVITY |
| 03/16/2006 | WO2005115441A3 Compositions and methods for enhanced mucosal delivery of parathyroid hormone |
| 03/16/2006 | US20060058398 Medicinal compositions containing vitamin k's as nerve growth factor potentiator and utilization thereof |
| 03/16/2006 | US20060057648 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) |
| 03/16/2006 | CA2579886A1 Novel imidazolidine derivative and use thereof |
| 03/16/2006 | CA2579204A1 Carbamoyl-substituted spiro derivative |
| 03/16/2006 | CA2578952A1 Waxy corn starch and use thereof for treating obesity and diabetes |
| 03/16/2006 | CA2577408A1 Use of (halobenzyloxy) benzylamino-propanamides for the manufacture of medicaments active as sodium and/or calcium channel selective modulators |
| 03/15/2006 | EP1634874A1 Imidazolidine derivative |
| 03/15/2006 | EP1634081A2 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 7 (5-ht7) |
| 03/15/2006 | EP1633883A1 Method for assaying lkb1 phosphorylation activity |
| 03/15/2006 | EP1633699A2 Aryl-carbaldehyde oxime derivatives and their use as estrogenic agents |
| 03/15/2006 | EP1633692A2 Cyclohexyl derivatives as selective estrogen receptor modulators |
| 03/15/2006 | EP1390039B1 Use of estrogen compounds to increase libido in women |
| 03/15/2006 | EP1383498B1 Crf receptor antagonists |
| 03/15/2006 | EP1326864B1 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 03/15/2006 | EP1227085B1 Process for producing optically active naphthalene derivative and optical resolver therefor |
| 03/14/2006 | US7012146 Modulators of all three classes of calcium channel blocker subtypes (Small, Intermediate and Big conductance K channel (SK, IK and BK)) comprising malonate esters and nitriles; respiratory, brain, cardiovascular, urogenital disorders |
| 03/14/2006 | CA2214070C Dihydronaphthalene and naphthalene compounds, intermediates, formulations, and methods |
| 03/09/2006 | WO2006024942A1 Androgen modulators |
| 03/09/2006 | WO2006024689A1 Use of a selective estrogen receptor modulator for the manufacture of a pharmaceutical preparation for use in a method for the treatment or prevention of androgen deficiency |
| 03/09/2006 | US20060052594 New corticosteroids |
| 03/09/2006 | US20060052289 Use of somatostatin analogs in sleep apnea |
| 03/09/2006 | US20060051433 Composition for accelerating secretion of estrogen and regenerating tissue cells of female sexual organs |